Defects in NK and NKT cell activities have been implicated in the etiology
of type 1 (autoimmune) diabetes in NOD mice on the basis of experiments per
formed using surrogate phenotypes for the identification of these lymphocyt
e subsets. Here, we have generated a congenic line of NOD mice (NOD.b-Nkrp1
(b)) which express the allelic NK1.1 marker, enabling the direct study of N
K and NKT cells in NOD mice. Major deficiencies in both populations were id
entified when NOD.b-Nkrp1(b) mice were compared with C57BL/6 and BALB.B6-Cm
v1(r) mice by flow cytometry. The decrease in numbers of peripheral NK cell
s was associated with an increase in their numbers in the bone marrow, sugg
esting that a defect in NK cell export may be involved. In contrast, the mo
st severe deficiency of NKT cells found was in the thymus, indicating that
defects in thymic production were probably responsible. The deficiencies in
NK cell activity in NOD mice could only partly be accounted for by the red
uced numbers of NK cells, and fewer NKT cells from NOD mice produced IL-4 f
ollowing stimulation, suggesting that NK and NKT cells from NOD mice shared
functional deficiencies in addition to their numerical deficiencies. Despi
te the relative lack of IL-4 production by NOD NKT cells, adoptive transfer
of alpha beta TCR(+)NK1.1(+) syngeneic NKT cells into 3-week-old NOD recip
ients successfully prevented the onset of spontaneous diabetes. As both NK
and NKT cells play roles in regulating immune responses, we postulate that
the synergistic defects reported here contribute to the susceptibility of N
OD mice to autoimmune disease.